标题
Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor
作者
关键词
-
出版物
PHARMACOLOGICAL RESEARCH
Volume 194, Issue -, Pages 106843
出版商
Elsevier BV
发表日期
2023-07-04
DOI
10.1016/j.phrs.2023.106843
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses
- (2023) Paulina E. Stürzebecher et al. ATHEROSCLEROSIS
- Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network
- (2023) Alberico L. Catapano et al. ATHEROSCLEROSIS
- Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society
- (2023) Florian Kronenberg et al. ATHEROSCLEROSIS
- Toll-Like Receptor 3 Mediates Aortic Stenosis Through a Conserved Mechanism of Calcification
- (2023) Can Gollmann-Tepeköylü et al. CIRCULATION
- Multiancestry Genome-Wide Association Study of Aortic Stenosis Identifies Multiple Novel Loci in the Million Veteran Program
- (2023) Aeron M. Small et al. CIRCULATION
- Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein
- (2023) Peter E Thomas et al. EUROPEAN HEART JOURNAL
- Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion
- (2022) Amer Youssef et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target
- (2022) Marlys L. Koschinsky et al. ATHEROSCLEROSIS
- Recent advances in demystifying the metabolism of lipoprotein(a)
- (2022) Kévin Chemello et al. ATHEROSCLEROSIS
- Lipoprotein(a): An underestimated inflammatory mastermind
- (2022) Kim E. Dzobo et al. ATHEROSCLEROSIS
- Lipoprotein(a) and ethnicities
- (2022) Anurag Mehta et al. ATHEROSCLEROSIS
- Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene
- (2022) Stefan Coassin et al. ATHEROSCLEROSIS
- Existing and emerging strategies to lower Lipoprotein(a)
- (2022) Gregory G. Schwartz et al. ATHEROSCLEROSIS
- Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis
- (2022) Michael B. Boffa ATHEROSCLEROSIS
- Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology
- (2022) Marlys L. Koschinsky et al. ATHEROSCLEROSIS
- Mendelian Randomization: Principles and its usage in Lp(a) research
- (2022) Claudia Lamina ATHEROSCLEROSIS
- Non-genetic influences on lipoprotein(a) concentrations
- (2022) Byambaa Enkhmaa et al. ATHEROSCLEROSIS
- Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?
- (2022) Florian Kronenberg ATHEROSCLEROSIS
- Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective
- (2022) Benoit J. Arsenault et al. ATHEROSCLEROSIS
- Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels
- (2022) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study
- (2022) Sofie Bay Simony et al. ATHEROSCLEROSIS
- Understanding the ins and outs of lipoprotein (a) metabolism
- (2022) Michael B. Boffa et al. CURRENT OPINION IN LIPIDOLOGY
- Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification
- (2022) Yannick Kaiser et al. EUROPEAN HEART JOURNAL
- Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial
- (2022) Stephen J. Nicholls et al. NATURE MEDICINE
- Consensus and guidelines on lipoprotein(a) – seeing the forest through the trees
- (2022) Florian Kronenberg et al. CURRENT OPINION IN LIPIDOLOGY
- Lipoprotein(a) and aortic valve stenosis: work in progress
- (2022) Florian Kronenberg EUROPEAN HEART JOURNAL
- Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
- (2022) Florian Kronenberg et al. EUROPEAN HEART JOURNAL
- Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes
- (2022) Paul Lacaze et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease
- (2022) Steven E Nissen et al. Open Heart
- Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood
- (2022) Olli Raitakari et al. CIRCULATION
- Commutability Assessment of Candidate Reference Materials for Lipoprotein(a) by Comparison of a MS-based Candidate Reference Measurement Procedure with Immunoassays
- (2022) Ioannis Dikaios et al. CLINICAL CHEMISTRY
- Development of an LC-MRM-MS-Based Candidate Reference Measurement Procedure for Standardization of Serum Apolipoprotein (a) Tests
- (2022) L Renee Ruhaak et al. CLINICAL CHEMISTRY
- The effect of menopause on lipoprotein (a) concentrations: A systematic review and meta-analysis
- (2022) Panagiotis Anagnostis et al. MATURITAS
- Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
- (2022) Michelle L. O’Donoghue et al. NEW ENGLAND JOURNAL OF MEDICINE
- The German Lipoprotein Apheresis Registry—Summary of the ninth annual report
- (2022) Volker J. J. Schettler et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Lipoprotein(a) and Aortic Valve Calcification
- (2022) Harpreet S. Bhatia et al. JACC-Cardiovascular Imaging
- Lipoprotein(a)-related cardiovascular and all-cause mortalities in Korean adults
- (2022) Byung Jin Kim et al. European Journal of Preventive Cardiology
- Genome-Wide Association Study and Identification of a Protective Missense Variant on Lipoprotein(a) Concentration
- (2021) M. Abdullah Said et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2021) Glen J. Pearson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease
- (2021) Johanna F. Schachtl-Riess et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of lipoprotein(a) with intrinsic and on-clopidogrel platelet reactivity
- (2021) Alexander Kille et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Long Noncoding RNA MIAT Controls Advanced Atherosclerotic Lesion Formation and Plaque Destabilization
- (2021) Francesca Fasolo et al. CIRCULATION
- Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
- (2021) Yannick Kaiser et al. HEART
- Lipoprotein(a): Knowns, unknowns and uncertainties
- (2021) Massimiliano Ruscica et al. PHARMACOLOGICAL RESEARCH
- Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis
- (2021) Lotte M de Boer et al. European Journal of Preventive Cardiology
- Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
- (2020) Sotirios Tsimikas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation
- (2020) Johan G. Schnitzler et al. CIRCULATION RESEARCH
- Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a)
- (2020) Lotte C A Stiekema et al. EUROPEAN HEART JOURNAL
- Gene-based therapy in lipid management: the winding road from promise to practice
- (2020) Tycho R. Tromp et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
- (2020) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functions of the Plasminogen Receptor , Plg‐R KT
- (2020) Lindsey A. Miles et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)
- (2020) Gerald F. Watts et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Relation of High Lipoprotein (a) Concentrations to Platelet Reactivity in Individuals with and Without Coronary Artery Disease
- (2020) Rocío Salsoso et al. ADVANCES IN THERAPY
- Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
- (2020) Michael Szarek et al. EUROPEAN HEART JOURNAL
- Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration
- (2020) Christa M Cobbaert et al. CLINICAL CHEMISTRY
- Lipoprotein(a) and Cardiovascular Disease
- (2020) Pia R Kamstrup CLINICAL CHEMISTRY
- Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a)
- (2020) Santica M Marcovina et al. CLINICAL CHEMISTRY
- Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial
- (2019) Michelle L. O'Donoghue et al. CIRCULATION
- Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis
- (2019) Sotirios Tsimikas CIRCULATION RESEARCH
- Statin therapy increases lipoprotein(a) levels
- (2019) Sotirios Tsimikas et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis
- (2019) Kang H. Zheng et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
- (2019) Dick C. Chan et al. Journal of the American Heart Association
- Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes
- (2019) Claudia Lamina et al. JAMA Cardiology
- Potent reduction of plasma lipoprotein(a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis
- (2019) Michael B. Boffa et al. JOURNAL OF LIPID RESEARCH
- Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays
- (2019) Hubert Scharnagl et al. ATHEROSCLEROSIS
- The challenges of measuring Lp(a): A fight against Hydra?
- (2019) Florian Kronenberg et al. ATHEROSCLEROSIS
- Statins and increases in Lp(a): an inconvenient truth that needs attention
- (2019) Sotirios Tsimikas et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention
- (2019) Christian M. Madsen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities
- (2019) A. Vuorio et al. JOURNAL OF INTERNAL MEDICINE
- Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes
- (2019) Daniel F. Gudbjartsson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic Factors Explain a Major Fraction of the 50% Lower Lipoprotein(a) Concentrations in FinnsHighlights
- (2018) Gertraud Erhart et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics
- (2018) Gerald F Watts et al. EUROPEAN HEART JOURNAL
- Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. JAMA Cardiology
- Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies
- (2018) Stephen Burgess et al. JAMA Cardiology
- Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment
- (2018) Lotte C A Stiekema et al. EUROPEAN HEART JOURNAL
- Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
- (2018) Peter Willeit et al. LANCET
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipoprotein(a) catabolism: a case of multiple receptors
- (2018) Sally P.A. McCormick et al. PATHOLOGY
- A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction
- (2017) Stefan Coassin et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium
- (2017) Christoph Waldeyer et al. EUROPEAN HEART JOURNAL
- Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial
- (2017) Tina Z. Khan et al. EUROPEAN HEART JOURNAL
- The metabolism of lipoprotein (a): an ever-evolving story
- (2017) Gissette Reyes-Soffer et al. JOURNAL OF LIPID RESEARCH
- A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms
- (2017) Salome Mack et al. JOURNAL OF LIPID RESEARCH
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- (2017) A. Michael Lincoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9
- (2017) Rocco Romagnuolo et al. PLoS One
- Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular DiseaseHighlights
- (2016) Eberhard Roeseler et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis
- (2016) Calvin Yeang et al. CARDIOVASCULAR DRUGS AND THERAPY
- Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in HumansClinical Perspective
- (2016) Fleur M. van der Valk et al. CIRCULATION
- Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
- (2016) Gissette Reyes-Soffer et al. CIRCULATION
- Recycling of Apolipoprotein(a) After PlgRKT-Mediated Endocytosis of Lipoprotein(a)Novelty and Significance
- (2016) Monika Sharma et al. CIRCULATION RESEARCH
- SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a)CLINICAL PERSPECTIVE
- (2016) Xiaoping Yang et al. Circulation-Cardiovascular Genetics
- Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease
- (2016) M. J. Nsaibia et al. JOURNAL OF INTERNAL MEDICINE
- PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor’s role
- (2016) Frederick J. Raal et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
- (2016) Børge G. Nordestgaard et al. JOURNAL OF LIPID RESEARCH
- Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels
- (2016) Connor A. Emdin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- High-density lipoprotein cholesterol on a roller coaster: where will the ride end?
- (2016) Florian Kronenberg KIDNEY INTERNATIONAL
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
- (2016) Nicholas J Viney et al. LANCET
- Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials
- (2016) Amirhosssein Sahebkar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a)CLINICAL PERSPECTIVE
- (2016) Xiaoping Yang et al. Circulation-Cardiovascular Genetics
- Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic ValveCLINICAL PERSPECTIVE
- (2015) Rihab Bouchareb et al. CIRCULATION
- Lipoprotein(a) Catabolism Is Regulated by Proprotein Convertase Subtilisin/Kexin Type 9 through the Low Density Lipoprotein Receptor
- (2015) Rocco Romagnuolo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)
- (2015) Corey A. Scipione et al. JOURNAL OF LIPID RESEARCH
- Mendelian randomization: genetic anchors for causal inference in epidemiological studies
- (2014) G. Davey Smith et al. HUMAN MOLECULAR GENETICS
- Dramatic lowering of very high Lp(a) in response to niacin
- (2014) Min Li et al. Journal of Clinical Lipidology
- Lipoprotein(a) Levels in Familial Hypercholesterolemia
- (2014) Rodrigo Alonso et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)
- (2014) Frederick J. Raal et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population
- (2014) Elaine T. Lim et al. PLoS Genetics
- Causes and consequences of lipoprotein(a) abnormalities in kidney disease
- (2013) Florian Kronenberg Clinical and Experimental Nephrology
- Lipoprotein(a): resurrected by genetics
- (2013) F. Kronenberg et al. JOURNAL OF INTERNAL MEDICINE
- Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)
- (2013) Gregor Leibundgut et al. JOURNAL OF LIPID RESEARCH
- Scavenger receptor-BI is a receptor for lipoprotein(a)
- (2013) Xiao-Ping Yang et al. JOURNAL OF LIPID RESEARCH
- Elevated Expression of Lipoprotein-Associated Phospholipase A2 in Calcific Aortic Valve Disease
- (2013) Ablajan Mahmut et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
- (2013) Pia R. Kamstrup et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic Associations with Valvular Calcification and Aortic Stenosis
- (2013) George Thanassoulis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis
- (2012) Pia R. Kamstrup et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions
- (2012) Rogier A. van Dijk et al. JOURNAL OF LIPID RESEARCH
- Nicotinic acid inhibits hepaticAPOAgene expression: studies in humans and in transgenic mice
- (2012) Indumathi Chennamsetty et al. JOURNAL OF LIPID RESEARCH
- Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism
- (2012) Anna Helgadottir et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) metabolism: Potential sites for therapeutic targets
- (2012) Jane Hoover-Plow et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Apolipoprotein(a) stimulates nuclear translocation of β-catenin: a novel pathogenic mechanism for lipoprotein(a)
- (2012) Taewoo Cho et al. MOLECULAR BIOLOGY OF THE CELL
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipoprotein-Derived Lysophosphatidic Acid Promotes Atherosclerosis by Releasing CXCL1 from the Endothelium
- (2011) Zhe Zhou et al. Cell Metabolism
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Atherogenic Lipids and Lipoproteins Trigger CD36-TLR2-Dependent Apoptosis in Macrophages Undergoing Endoplasmic Reticulum Stress
- (2010) Tracie A. Seimon et al. Cell Metabolism
- Lipoprotein(a) accelerates atherosclerosis in uremic mice
- (2010) Tanja X. Pedersen et al. JOURNAL OF LIPID RESEARCH
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- (2009) Pia R. Kamstrup JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein(a), through Its Strong Lysine-binding Site in KIV10, Mediates Increased Endothelial Cell Contraction and Permeability via a Rho/Rho Kinase/MYPT1-dependent Pathway
- (2008) Taewoo Cho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma
- (2008) Claes Bergmark et al. JOURNAL OF LIPID RESEARCH
- Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia
- (2008) Frederick F Samaha et al. Nature clinical practice. Cardiovascular medicine
- Nicotinic Acid: Pharmacological Effects and Mechanisms of Action
- (2007) Andreas Gille et al. Annual Review of Pharmacology and Toxicology
- Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population
- (2007) Pia R. Kamstrup et al. CIRCULATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started